3、受金融市场利率持续下降影响，理财收益有所下降；新投资子公司尚处于初创、培育阶段，尚未形 成规模收入，费用有所增加；导致年度内期间费用有所上升。未来，公司将积极采取措施，加大市场开 拓力度，提升营业规模；增加成本费用控制手段，提升经营利润；加大货款催收力度，提升应收账款周 转率；努力提升公司综合竞争力，改善经营业绩。 证券之星消息，港通医疗发布业绩预告，预计2025年全年扣非后净利润亏损600万元至1000万元。 公告中解释本次业绩变动的原因为： 1、报告期内，公司主要合同执行进度不及预期，公司营业收入有所下降。 2、公司客户主要系公立医院、国资公司等单位，受财政资金、审计结算周期等影响，公司回款周期加 长，应收账款增加，应收账款减值准备计提有所增加。 港通医疗2025年三季报显示，前三季度公司主营收入3.44亿元，同比下降30.06%；归母净利润-1020.84 万元，同比下降150.92%；扣非净利润-1286.52万元，同比下降176.82%；其中2025年第三季度，公司单 季度主营收入7911.64万元，同比上升42.81%；单季度归母净利润-180.4万元，同比下降138.94%；单季 度扣非净利 ...

（记者 王晓波） 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每经AI快讯，港通医疗1月29日晚间发布业绩预告，预计2025年归属于上市公司股东的净利润亏损200 万元~400万元，同比由盈转亏。业绩变动主要原因是：报告期内，公司主要合同执行进度不及预期， 公司营业收入有所下降。公司客户主要系公立医院、国资公司等单位，受财政资金、审计结算周期等影 响，公司回款周期加长，应收账款增加，应收账款减值准备计提有所增加。受金融市场利率持续下降影 响，理财收益有所下降；新投资子公司尚处于初创、培育阶段，尚未形成规模收入，费用有所增加；导 致年度内期间费用有所上升。未来，公司将积极采取措施，加大市场开拓力度，提升营业规模；增加成 本费用控制手段，提升经营利润；加大货款催收力度，提升应收账款周转率；努力提升公司综合竞争 力，改善经营业绩。 每日经济新闻 每经头条（nbdtoutiao）——水贝黄金平台"杰我睿"兑付危机调查：40倍杠杆对赌，金价越涨平台越 亏！老板自称"还在深圳"，投资者：兑付方案本金打两折，无法接受 ...

证券代码：301515 证券简称：港通医疗 公告编号：2026-001 四川港通医疗设备集团股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二）业绩预告情况：预计净利润为负值 （1）以区间数进行业绩预告的 | 项 目 | 本报告期 | | | | 上年同期 | | | --- | --- | --- | --- | --- | --- | --- | | 归属于上市公司股东的净利润 | 亏损：200.00 | 万元 | 万元 ~ 400.00 | | 盈利：1,442.19 | 万元 | | 归属于上市公司股东扣除非经常性 | 亏损：600.00 ~ | 万元 | 1,000.00 | 万元 | 盈利：500.84 | 万元 | | 损益后的净利润 | | | | | | | 二、与会计师事务所沟通情况 本次业绩预告相关数据是公司财务部门初步测算结果，未经会计师事务所审计。 公司已就业绩预告有关事项与会计师事务所 ...

Core Viewpoint - The company expects to achieve a net profit of 7.7 million to 10 million yuan for the year 2025, indicating a turnaround from previous losses, while the net profit excluding non-recurring gains and losses is projected to be between -1.2 million and -600,000 yuan [1] Group 1: Performance Expectations - The company anticipates a significant improvement in net profit for 2025 compared to the previous year, indicating a successful recovery from losses [1] - The projected net profit range for 2025 is between 7.7 million and 10 million yuan, while the adjusted net profit is expected to be between -1.2 million and -600,000 yuan [1] Group 2: Business Strategy and Operations - The company has optimized its business layout, which has led to an overall enhancement in profitability [1] - The expansion into overseas markets has shown positive results, with the HVLS fan business seeing an increase in foreign sales revenue, contributing to a steady growth in overall gross margin [1] - Continuous optimization of operational management and implementation of cost-reduction measures have effectively controlled management and sales expenses, further solidifying the company's profitability foundation [1]

证券之星消息，截至2026年1月28日收盘，港通医疗(301515)报收于24.11元，下跌1.27%，换手率 2.67%，成交量1.75万手，成交额4243.07万元。 1月28日的资金流向数据方面，主力资金净流出158.4万元，占总成交额3.73%，游资资金净流出324.57 万元，占总成交额7.65%，散户资金净流入482.98万元，占总成交额11.38%。 近5日资金流向一览见下表： | 日期 | | | | | 收盘价 涨跌幅 主力净流入 主力净占比 游资净占比 散户净流入 散户净占比 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2026-01-28 | 24.11 | -1.27% | -158.40万 | -3.73% | -324.57万 | -7.65% | 482.98万 | 11.38% | | 2026-01-27 | 24.42 | -1.13% | -296.99万 | -4.92% | -119.54万 | -1.98% | 416.53万 | 6.90% | | 2026-01-26 | | ...

Group 1 - The company Kaili Co., Ltd. announced a change in its auditing firm for the fiscal year 2025, with Tianjian Accounting Firm (Special General Partnership) replacing the signing auditor Lv Yingqun with Zhu Dawei [2] - The new signing auditors will be Zhu Dawei and Guo Yunhua, who will continue to complete the financial statements and internal control audit for the fiscal year 2025 [2]

Group 1 - The company responded to an investor inquiry regarding the number of shareholders as of January 20, 2026, stating that the total number of shareholders will be 9,594 [1]

Group 1 - The core viewpoint of the article is that 港通医疗 (Kangtong Medical) has provided information regarding its shareholder count as of January 20, 2026, indicating a total of 9,594 shareholders [2] Group 2 - The company responded to an investor inquiry about the number of shareholders, confirming the total count [2] - The information was shared through an investor relations platform, highlighting the company's engagement with its investors [1]

Group 1 - The company has recently secured project orders in African countries such as Kenya, Tunisia, and Djibouti [1] - The company encourages investors to monitor announcements on designated media platforms for major information disclosures [1]

Group 1 - The core viewpoint of the article is that the company, 港通医疗 (301515.SZ), has successfully secured project orders in various African regions, including Kenya, Tunisia, and Djibouti [1] Group 2 - The company has been actively expanding its operations in Africa, indicating a strategic focus on international markets [1] - The recent project orders reflect the company's growth and potential in the healthcare sector within these emerging markets [1]